Loading

Press Release

Sensus Healthcare Reports Fourth Quarter and Full Year 2020 Financial Results

Sensus Healthcare Reports Fourth Quarter and Full Year 2020 Financial Results

Achieves fourth quarter net income of $1.0 million on revenues of $5.1 million Conference call begins at 4:30 p.m. Eastern…

See More
Sensus Healthcare Granted U.S. Patent for Three-Dimensional Beam Forming X- Ray Source

Sensus Healthcare Granted U.S. Patent for Three-Dimensional Beam Forming X- Ray Source

Patent covers beam splitting and sculpting capabilities of radiation to treat all types of solid tumors with SculpturaTM and potentially…

See More
Holy Name Medical Center in Teaneck, New Jersey Acquires Sensus Healthcare’s  Low-dose Radiation Therapy System to Treat Pneumonia in COVID-19 Patients

Holy Name Medical Center in Teaneck, New Jersey Acquires Sensus Healthcare’s Low-dose Radiation Therapy System to Treat Pneumonia in COVID-19 Patients

BOCA RATON, Fla. (January 6, 2021) – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective,…

See More
Sensus Healthcare Engages Ekpac Healthcare Ltd. as New Exclusive Distributor in China for SRT-100™ Systems

Sensus Healthcare Engages Ekpac Healthcare Ltd. as New Exclusive Distributor in China for SRT-100™ Systems

Agreement is for the treatment of non-melanoma skin cancer and keloids, covers China and Hong Kong and is effective January…

See More
Sensus Healthcare Announces CMS Sets Rates Higher for SRT Reimbursement

Sensus Healthcare Announces CMS Sets Rates Higher for SRT Reimbursement

Centers for Medicare & Medicaid Services sets a 66% increase in reimbursement for Radiation Treatment Delivery code 77401, and increases…

See More
American Society of Radiologic Technologists Approves Sensus Healthcare’s SRT Systems for Continuing Education Units

American Society of Radiologic Technologists Approves Sensus Healthcare’s SRT Systems for Continuing Education Units

Beginning September 1, Category A credits will be available for in-person trainings on the SRT-100™, SRT-100+™ and SRT-100 Vision™ systems…

See More
Sensus Healthcare Acquires Two Mobile Aesthetic Laser Companies in Florida

Sensus Healthcare Acquires Two Mobile Aesthetic Laser Companies in Florida

Establishes new line of business, adds recurring revenue stream while more than doubling dermatology customer base across the state Expected…

See More
Sensus Healthcare Names Hoi-Bun “Benson” Suen Vice President of International Sales, Ships SRT-100™ to China

Sensus Healthcare Names Hoi-Bun “Benson” Suen Vice President of International Sales, Ships SRT-100™ to China

BOCA RATON, Fla. (July 28, 2020) – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective,…

See More
ASTRO Defines SRT as a First Line Treatment for Non-Melanoma Skin Cancer

ASTRO Defines SRT as a First Line Treatment for Non-Melanoma Skin Cancer

Influential professional organization recommends radiotherapy as the primary non-surgical alternative for patients with basal cell or cutaneous squamous cell carcinomas…

See More
South Florida Business Journal: Executive Profile: Sensus Healthcare CEO Joe Sardano

South Florida Business Journal: Executive Profile: Sensus Healthcare CEO Joe Sardano

Our CEO, Chairman, and Founder Joe Sardano, sat down with South Florida Business Journal’s (SFPJ) digital editor Emon Reiser to…

See More
Sensus Healthcare Announces Publication of Research on Long-term Efficacy and Safety of Superficial Radiation Therapy in Journal of Drugs in Dermatology

Sensus Healthcare Announces Publication of Research on Long-term Efficacy and Safety of Superficial Radiation Therapy in Journal of Drugs in Dermatology

Retrospective registry study showed a 98.9% non-recurrence rate after 85 months in subjects with non-melanoma skin cancer treated with SRT…

See More
Sensus Healthcare Announces Sculptura™ Shipment to California-based Medical Center Third Sculptura system sold worldwide

Sensus Healthcare Announces Sculptura™ Shipment to California-based Medical Center Third Sculptura system sold worldwide

BOCA RATON, Fla, Jan. 22, 2020 (GLOBE NEWSWIRE) — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly…

See More
Sensus Healthcare Awarded Brachytherapy Products Agreement with Premier

Sensus Healthcare Awarded Brachytherapy Products Agreement with Premier

Sensus Healthcare, Inc. has been awarded a group purchasing agreement for Brachytherapy Products with Premier. Effective August 1, 2019, the…

See More
Five-Year Retrospective Study Shows Topline Results for Patients Treated with Sensus Healthcare’s Superficial Radiation Therapy

Five-Year Retrospective Study Shows Topline Results for Patients Treated with Sensus Healthcare’s Superficial Radiation Therapy

Sensus Healthcare, Inc. announces topline results from a five-year retrospective study of non-melanoma skin cancer (NMSC) patients treated with Superficial…

See More
Sensus Healthcare Launches SRT University, an Online Portal to Support Physicians

Sensus Healthcare Launches SRT University, an Online Portal to Support Physicians

Sensus Healthcare, Inc. launches SRT University, an online portal to support physicians using Sensus devices and technology. The new online…

See More
Sensus Healthcare Announces FDA Market Clearance for Sensus Healthcare’s New Sculptura™ Radiation Oncology System

Sensus Healthcare Announces FDA Market Clearance for Sensus Healthcare’s New Sculptura™ Radiation Oncology System

Sensus Healthcare, Inc., a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announced…

See More
Sensus Healthcare Profiled in Future Market Insights Report–Global Keloid Treatment Market to Collect $4,414.6 Million by 2027 End

Sensus Healthcare Profiled in Future Market Insights Report–Global Keloid Treatment Market to Collect $4,414.6 Million by 2027 End

Valley Cottage, New York, Oct. 30, 2017 (GLOBE NEWSWIRE) — According to the latest market report published by FMI titled…

See More
Sensus Healthcare Announces Low 3% Keloid Recurrence in Multicenter Case Series of 297 Patients Treated with Superficial Radiation Therapy

Sensus Healthcare Announces Low 3% Keloid Recurrence in Multicenter Case Series of 297 Patients Treated with Superficial Radiation Therapy

SRT-100, a Low-energy X-ray Technology, Used at Site of Keloidectomy Treatment BOCA RATON, Fla., Dec. 6, 2018 /PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), a…

See More
Sensus Healthcare Installs First Groundbreaking SRT-100+ Superficial Radiation Therapy System for Treating Keloid Scars

Sensus Healthcare Installs First Groundbreaking SRT-100+ Superficial Radiation Therapy System for Treating Keloid Scars

Dr. Kenrick Spence of Hillcrest Plastic Surgery in Orlando First to Offer System BOCA RATON, Fla., Nov. 29, 2018,/PRNewswire/ — Sensus…

See More
Sensus Healthcare Receives FDA 501(k) Clearance to Market Next-Generation SRT-100+ Superficial Radiation Therapy for Treating Non-Melanoma Skin Cancer and Keloids

Sensus Healthcare Receives FDA 501(k) Clearance to Market Next-Generation SRT-100+ Superficial Radiation Therapy for Treating Non-Melanoma Skin Cancer and Keloids

SRT-100+ Offers Advanced Features for Patients and Doctors, Including Remote Diagnostics and Patient Medical Records Integration, as well as Core…

See More

Contact Us

Fill out the form below to find out more!